FrançaisAre analysts right about Pediatrix Medical Group (MD)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Pediatrix Medical Group, we replayed every analyst price target of the past 12 months and measured the real outcome: 44% were profitable, average return +4% (62 calls). At 3 months: -3% average return (34% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Credit Suisse | 15 | 27% | -1% |
| Jefferies | 10 | 80% | +22% |
| Stifel | 7 | 29% | +6% |
| Deutsche Bank | 6 | 33% | -12% |
Frequently asked questions
Is Pediatrix Medical Group a buy right now?
The analyst consensus on Pediatrix Medical Group (MD) is "Hold" (0 bullish, 0 bearish calls over 12 months). This is not advice: historically, 44% of their targets on this stock turned out profitable over 1 year.
What is Pediatrix Medical Group's price target?
The median 12-month price target is $28.00 (+4% vs $26.80), ranging from $28.00 to $28.00 (3 analysts).
Are analysts accurate on Pediatrix Medical Group?
Over 1 year, 44% of analyst targets on Pediatrix Medical Group were profitable, for an average return of +4% (across 62 timestamped calls). This is JPI Invest's accuracy metric.
What is the Pediatrix Medical Group stock forecast?
Analysts target a median of $28.00 within 12 months, i.e. +4% vs the current price. The most bullish targets $28.00, the most cautious $28.00.
What is the Pediatrix Medical Group stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $28.00, +4%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (44%), and the stock's past trajectory.
Is Pediatrix Medical Group overvalued?
Detailed valuation data for Pediatrix Medical Group is available in the interactive analysis.
📊 See the full interactive analysis of Pediatrix Medical Group →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.